Market Cap (In TWD)
3.2 Billion
Revenue (In TWD)
162.48 Million
Net Income (In TWD)
-47.11 Million
Avg. Volume
224.28 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 15.75-23.5
- PE
- -
- EPS
- -
- Beta Value
- 1.008
- ISIN
- TW0004108006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Yi-Li Lee
- Employee Count
- -
- Website
- https://www.phytohealth.com.tw
- Ipo Date
- 2008-07-16
- Details
- PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.
More Stocks
-
0450
-
STP
-
IFX
-
PCT
-
3694
-
1821
-
1809China Glaze Co.,Ltd.
1809
-
WRB-PF